Lateral flow assays market seen reaching $19.3 billion by 2030

The Business Research Company says the global lateral flow assays market is growing on demand for rapid diagnostics, infectious disease testing and home-based testing. The market is projected to rise from $12.29 billion in 2025 to $13.45 billion in 2026, with North America leading now and Asia-Pacific expected to grow fastest.

Why it matters: - Lateral flow assays are becoming more important as healthcare systems push for faster, more accessible testing. - The market's growth reflects broader demand for point-of-care diagnostics, home testing and real-time disease monitoring. - Infectious disease prevalence continues to create demand for rapid test formats across both developed and developing markets.

What happened: - The Business Research Company published its "Lateral Flow Assays Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The report estimates the market will grow from $12.29 billion in 2025 to $13.45 billion in 2026. - The report projects the market will reach $19.3 billion by 2030. - The report was released Aug. 13, 2026, from London. - A free sample of the report and the full market report are available online.

The details: - The report says the market is growing because of rising demand for quick diagnostic solutions, broader infectious disease testing, widespread use of rapid test kits, decentralized healthcare models and greater awareness of early disease detection. - The forecast period assumes continued growth in home-based diagnostic tools, digital health integration, multiplex testing, rapid diagnostic innovation and real-time disease monitoring. - The report highlights wider adoption of point-of-care rapid diagnostics, greater use of multiplex lateral flow assays, more digital readers, growth in veterinary and domestic testing, and higher test sensitivity. - A lateral flow assay includes four main parts: a sample pad, a conjugate pad, a reaction membrane with test and control lines, and an absorbent pad. - The sample pad receives the test sample. - The conjugate pad contains labelled tags combined with biorecognition elements. - The reaction membrane identifies antigen-antibody interactions. - The absorbent pad collects waste from the testing process. - Infectious disease prevalence remains a key driver, especially in countries with limited healthcare infrastructure and high burdens of HIV and malaria. - The COVID-19 pandemic increased focus on early detection technologies. - In August 2024, the UK Health Security Agency reported 368 measles cases in England in 2023, up from 53 in 2022. - The UKHSA said 44% of those cases were in the West Midlands and 33% were in London. - North America held the largest share of the global market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market story is shifting beyond pandemic-era testing toward a broader mix of home use, veterinary use and multiplex capabilities. - Digital readers and integrated health tools suggest the category is moving from simple strips toward more connected diagnostics. - Regional growth trends point to mature demand in North America and faster expansion in markets where access and disease burden are still driving test adoption.

What's next: - The Business Research Company expects continued investment in rapid diagnostic innovation. - Multiplex testing and digital readout features are likely to remain central themes in the market's next growth phase. - Demand should stay tied to infectious disease trends, especially where public health systems need affordable, fast testing. - The company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, market hotspot infographics and updated graphics and tables. - Contact information for report inquiries was included in the release, along with the company's social media links.

The bottom line: - Lateral flow assays are moving from a niche rapid-test category into a broader global diagnostics market with strong demand across point-of-care, home and veterinary testing.